Liquid chlorophyll is not 'the new Ozempic' — here's why

What did @tipsdedani actually say?

Honestly, the transcript here is nearly incomprehensible, which is itself a problem. What we can reconstruct from the caption and hashtags is the core claim: liquid chlorophyll is "el nuevo Ozempic" (the new Ozempic). The hashtags target belly fat, waist reduction, and body reshaping, and the product appears to be a chlorophyll liquid drop. The video pulled 174K views on that framing alone, which is why this needs addressing directly.

The creator does not appear to explain a mechanism, cite a study, or qualify the comparison in any meaningful way. The caption does include "results may vary," which is at least a gesture toward honesty. But calling any supplement "the new Ozempic" next to hashtags like "cintura de avispa" (wasp waist) and "cuerpo de guitarra" (guitar body) is making a weight-loss claim, full stop.

Does the science back this up?

No. There is no clinical evidence that liquid chlorophyll produces weight loss comparable to, or even meaningfully similar to, GLP-1 receptor agonists like semaglutide. These are pharmacologically different categories of things, and conflating them is not a small exaggeration.

GLP-1 receptor agonists work by binding to glucagon-like peptide-1 receptors, slowing gastric emptying, suppressing appetite through central nervous system pathways, and modulating insulin secretion. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed semaglutide produced a mean 14.9% body weight reduction over 68 weeks in adults with obesity. That is a drug effect with a known receptor mechanism.

Chlorophyll research is sparse and mostly limited to animal models or small human pilots. One study (Montelius et al., 2014, Appetite) found that thylakoid-rich spinach extract, not chlorophyll itself, reduced hunger and food cravings in women over 12 weeks. Thylakoids are not chlorophyll drops. The leap from that finding to "new Ozempic" is enormous and unsupported.

What did they get wrong (or right)?

The "new Ozempic" framing is wrong, and it is wrong in a way that could matter to real people. Someone managing their expectations around a chlorophyll supplement as a GLP-1 equivalent could delay seeking medical care for obesity or diabetes, conditions where timing of treatment has documented consequences.

The deodorant and body odor angle (the hashtags include sudor, mal aliento, axilas sudadas) is actually where chlorophyll has more legitimate, if modest, support. A study by Young and Beregi (1980, Journal of the American Geriatrics Society) found chlorophyllin reduced body odor in nursing home residents. More recent work suggests internal deodorant properties are real, though effect sizes are modest. If that is what this product is actually being sold for, the science is at least in the right zip code.

The weight loss and body-shaping claims, however, have no comparable support. Getting the deodorant angle right while getting the weight loss angle badly wrong is not a wash. The weight loss framing is what the 174K views are responding to.

What should you actually know?

Liquid chlorophyll, typically sold as sodium copper chlorophyllin in water, is not a GLP-1 receptor agonist. It does not slow gastric emptying. It does not act on hypothalamic appetite circuits. It has no documented effect on adipose tissue. Comparing it to semaglutide is like comparing a breath mint to a beta blocker because both affect something in your body.

The FTC has taken action against supplement companies making unsubstantiated weight loss claims, and the FDA classifies semaglutide as a prescription drug for a reason: it requires medical oversight, carries real side effect profiles, and demands monitoring. No supplement can legally claim equivalency with a prescription drug, and no responsible creator should imply it.

If you are looking at chlorophyll drops for their documented uses, the internal deodorant and potential antioxidant properties are worth discussing with a provider. If someone told you it would reshape your waist like Ozempic, they oversold it significantly. Actual GLP-1 treatment, when appropriate, requires a licensed provider, a prescription, and ongoing clinical monitoring.